Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Pentavalent human-bovine vaccine reduces rotavirus gastroenteritis

Jan. 26, 2006

Attenuated human rotavirus vaccine effective against severe gastroenteritis

Jan. 25, 2006

Unique IL-6 immunosuppressive activity of sanglifehrin A

Jan. 24, 2006

NovImmune files IND for antibody for autoimmune disease

Jan. 23, 2006

Tolamba shows clinical benefit in reducing symptoms of ragweed allergy

Jan. 23, 2006

ImmuneRegen BioSciences submits proposal to Department of Defense

Jan. 20, 2006

Novartis prepares and tests novel agents for transplant rejection

Jan. 19, 2006

Inhaled ciclosporin added to immunosuppression beneficial in lung transplant patients

Jan. 18, 2006

Enrollment open in phase IIb kidney transplant study of ISA-247

Jan. 13, 2006

FDA approval for subcutaneous immunoglobulin treatment Vivaglobin

Jan. 11, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...